Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
allergan
biotech
clinical trials
eli lilly
europe blog main
2
×
fda
2
×
life sciences
national blog main
national top stories
alkermes
amgen
biohaven
boston blog main
boston top stories
buprenorphine
cariprazine
cgpr
europe
europe top stories
felipe jain
jess fiedorowicz
jessica jeffrey
karim calis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
merck
migraine
national
national institutes of health (nih)
new york blog main
olanzapine
opioid
ottawa hospital
samidorphan
steven meisel
svb leerink
ucla
What
fda
treatment
2
×
adults
alkermes
allergan
antipsychotic
approved
benefits
caveats
class
commonly
designed
drug
effect
favor
gain
medicine
medicines
migraine
monday
new
nod
offer
panel
pill
prescribed
psyche
treat
ubrelvy
ubrogepant
vote
weighs
weight
wins
won
Language
unset
Current search:
fda
×
treatment
×
" europe blog main "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines